Abstract:Alzheimer’s disease (AD) is an age-related neurodegenerative disorder. Neuritic plaques containing amyloid-β protein (Aβ) and neurofibrillary tangles composed of hyperphosphorylated tau protein constitute major neuropathological hallmarks of AD. The neurotoxicity of aggregated Aβ has been implicated as a critical cause in the pathogenesis of AD. The aim of this study was to exam the use of neoagarohexaose (NAH) in the potential treatment of AD effects, using SH-SY5Y neuronal cell line exposed to β-amyloid protein (Aβ1-42). The present study was designed to explore the neuroprotective effects of NAH on neuroblastoma SH-SY5Y cells as a function of dosage. The cells were exposed to Aβ1-42 with or without NAH (26.7, 53.4, and 106.8 μM) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was used for detecting the viability of treated cells. In treated cells, the activities of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and malondialdehyde (MDA) were determined using their manufacturer kits. Flow cytometry analysis was used to assess apoptosis, changes in intracellular calcium concentration, and the mitochondrial membrane potential (MMP) after treatment. Additionally, changes in the mechanism of Aβ1-42 aggregation in the presence of NAH were explored using thioflavin T (ThT) and Congo red (CR) assays. The results showed that incubation with NAH prior to Aβ1-42 exposure increased cell survival and prevented reactive oxygen species generation. Moreover, NAH decreased the apoptotic rate, inhibited MMP depolarization, reversed the change in intracellular calcium concentration, enhanced the activities of SOD and GSH-Px, and decreased the level of MDA. In addition, the results showed that NAH, which reduced the absorption of the amyloid indicator ThT and CR dyes, was a potent inhibitor of Aβ fibrillogenesis. In conclusion, NAH protects SH-SH5Y cells from Aβ-induced damage by reducing oxidative stress and weakens the spontaneous amyloid formation of Aβ fibrils in vitro and can inhibit the amyloidization of amyloid β protein (Aβ). This study shows that NAH may be a promising anti-AD drug candidate for AD treatment.

Neoagarohexaose Protects Against Amyloid Β-Induced Oxidative Stress and Aggregation

A Newly Synthesized Rhamnoside Derivative Alleviates Alzheimer's Amyloid-β-Induced Oxidative Stress, Mitochondrial Dysfunction, and Cell Senescence Through Upregulating SIRT3.

Protective effect of EGb761 against Aβ1-42 -induced SHSY5Y cells injury and blood-brain barrier disruption via regulating Akt/Nrf2 signaling pathway

C3N Nanodots Inhibits Aβ Peptides Aggregation Pathogenic Path in Alzheimer's Disease.

Stimulation of autophagy prevents amyloid-β peptide-induced neuritic degeneration in PC12 cells.

Acteoside protects human neuroblastoma SH-SY5Y cells against beta-amyloid-induced cell injury.

A Traditional Chinese Medicine, YXQN, Reduces Amyloid-induced Cytotoxicity by Inhibiting Aβ42 Aggregation and Fibril Formation

Noradrenaline Protects Human Microglial Cells (HMC3) Against Apoptosis and DNA Damage Induced by LPS and Aβ1-42 Aggregates In Vitro

Anti Alzheimer's effects of Neem oil nanoemulsion against Amyloid β1-40 induced in human neuroblastoma SH-SY5Y cell line

Acteoside protects human neuroblastoma SH-SY5Y cells against β-amyloid-induced cell injury

Nicotinic Acid attenuates Amyloid β 1-42 -induced mitochondrial dysfunction and inhibits the mitochondrial pathway of apoptosis in differentiated SH-SY5Y cells.

A BBB-permeable Antioxidant Targeting Alzheimer's Amyloidogenesis

Macromolecular and small-molecule modulation of intracellular Aβ42 aggregation and associated toxicity.

Symptoms of immediate chlorhexidine hypersensitivity in patients with a positive prick test

Mapping of the pig genome.

Neuroprotective Effects of ZL006 in Aβ 1–42 -Treated Neuronal Cells

Serum albumin-embedding copper nanoclusters inhibit Alzheimer's β-amyloid fibrillogenesis and neuroinflammation

Ganoderic acid a decreased Aβ42-induced neurotoxicity in PC12 cells by reduced mitochondrial damage

Impact of Alternating Amino Acid Sequences on Beta-Amyloid-induced Neurotoxicity and Neuroinflammation in Alzheimer's Disease.

Probing the anti-Aβ42 aggregation and protective effects of prenylated xanthone against Aβ42-induced toxicity in transgenic Caenorhabditis elegans model

In vitro evaluation of the protective effects of plant extracts against amyloid-beta peptide-induced toxicity in human neuroblastoma SH-SY5Y cells